#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

The way to the diagnosis of alveolar proteinosis: what is decisive?


Authors: Mária Makovická 1,2;  Adela Vrbenská 3;  Brigita Javorská 4;  Barbora Durcová 4;  Peter Makovický 1,2;  Jozef Škarda 5;  Jozef Muri 1,6
Authors‘ workplace: Ústav histologie a embryologie, Lékařská fakulta v Ostravě, Česká republika 1;  Ústav experimentálnej onkológie, Biomedicínske centrum SAV, v. v. i. v Bratislave, Slovenská republika 2;  Oddelenie patológie, Národný ústav tuberkulózy, pľúcnych chorôb a hrudníkovej chirurgie vo Vyšných Hágoch, Slovenská republika 3;  Oddelenie pneumológie a ftizeológie, Národný ústav tuberkulózy, pľúcnych chorôb a hrudníkovej chirurgie vo Vyšných Hágoch, Slovenská, republika 4;  Ústav klinické a molekulární patologie a lékařské genetiky, Lékařská fakulta v Ostravě, Česká republika 5;  Centrum hrudníkovej chirurgie, Národný ústav tuberkulózy, pľúcnych chorôb a hrudníkovej chirurgie vo Vyšných Hágoch, Slovenská, republika 6
Published in: Čes.-slov. Patol., 61, 2025, No. 1, p. 36-42
Category: Original Article

Overview

In this article, we describe the course and diagnosis of pulmonary alveolar proteinosis (PAP) based on two cases from our practice. The first case is a 52-yearold woman, the second a 34-year-old man. Both referred patients were examined by a pulmonologist for interstitial lung disease, in the first case also with transition to pulmonary fibrosis. As part of the differential diagnosis, these patients were hospitalized at the NÚTPCHaHCH in Vyšné Hágy. Chest X-ray showed diffuse bilateral lung infiltrates, in the first patient locally confluent. Chest CT showed parenchymal involvement of the lungs with bilateral ground-glass opacities with thickened interlobular septa (crazy paving). Bronchoscopic examination was performed in both patients with bronchoalveolar lavage, which had a characteristic milky-glazed appearance. Videothoracoscopic lung biopsy was additionally indicated and histopathologically there were pulmonary alveolar proteinosis confirmed. Therapeutically, the patients underwent large volume lung lavage, with clinical condition improvement, including radiological findings improvement. We point out the basic pillars of the diagnosis of pulmonary alveolar proteinosis, which are the pattern of pulmonary involvement in the radiographic and CT (or HRCT) images, the characteristic appearance of the bronchoalveolar lavage fluid, and additionally also the histopathologic pattern of pulmonary involvement in this disease. We emphasize the need for centralized management of patients with lung diseases, which is particularly urgent in cases of rare diseases, where it provides rapid availability of all relevant diagnostic and therapeutic options, including large-volume lung lavage.

Keywords:

Macrophages – pneumology – rare diseases – pulmonary alveolar proteinosis (PAP) – whole lung lavage (WLL)


Sources
  1. Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. The New England Journal of Medicine 1958; 258; 1123-1142.
  2. Javorská B, Slivka R, Durcová B, et al. Pulmonary alveolar proteinosis: Clinical ans morphological overview of a rare disease associated with macrophage dysfunction. General Physiology and Biophysics 2025; 44; in press.
  3. Iftikhar H, Nair GB, Kumar A. Update on diagnosis and treatment of adult pulmonary alveolar proteinosis. Therapeutics and Clinical Risk Management 2021; 17; 701-710.
  4. Salvaterra E, Campo I. Pulmonary alveolar proteinosis: from classification to theraphy. Breathe (Sheffield, England) 2020; 16(2); 200018.
  5. Carrington JM, Hershberger DM. Pulmonary alveolar proteinosis. StatPearls. Treasure Island (FL): StatPearls Publishing 2023.
  6. McCarthy C, Kokosi M, Bonella F. Shaping the future of an ultra-rare disease: unmet needs in the diagnosis and tretament of pulmonary alveolar proteinosis. Current Opinion in Pulmonary Medicine 2019; 5; 450-458.
  7. Bruter AV, Varlamova EA, Okulova YD, et al. Genetically modified mice as a tool for the study of human disease. Molecular Biology Reporrts 2024; 51(1); 135.
  8. Makovický P, Švecová I. Histopathology, past, present & future. Phenogenomics Newsletter 2016; 2(2); 14-15.
  9. Cai X, Zeng QS, Guan YB, Deng Y. Analysis of the imaging findings of pulmonary alveolar proteinosis. Di-san Junyi Daxue Xuebao 2005; 25(4); 441-443.
  10. Kim SH, Baek CO, Kim JH, Song SK. A rare case of Graves thyrotoxicosis with contomitant pulmonary alveolar proteinosis. Acta Endocrinologica (Bucharest) 2023; 19(2); 241-244.
  11. Nowers K, Rasband JD, Berges G, Gosselin M. Approach to ground-glass opacification of the lung. Seminars in Ultrasound, CT and MRI 2002; 4; 302-323.
  12. Donuru A, Torigian DA, Knollmann F. Uncommon causes of interlobular septal thickening on CT images and their distinguishing features. Tomography 2024; 10(4); 574-608.
  13. Kotov PV, Shidham VB. Alveolar proteinosis in a patient recovering from Pneumocystis carinii infection: a case report with a review of literature. Cytojournal 2006, 3; 22.
  14. Raj D, Bhutia TD, Mathur S, Kabra SK, Lodha R. Pulmonary alveolar proteinosis secondary to Pneumocystis jiroveci infection in an infant with common variable immunodeficiency. Indian Journal of Pediatrics 2014; 81(9); 929-931.
  15. Seymour JF, Presneill J. Pulmonary alveolar proteinosis: progress in the first 44 years. American Journal of Respiratory and Critical care Medicine 2002; 166(2); 215-235.
  1. Arai T, Inoue Y, Akira M, Nakata K, Kitaichi M. Autoimmune pulmonary alveolar proteinosis following pulmonary aspergillosis. Internal Medicine 2015; 54(24); 3177-3180.
  2. Brugnoli B, Salvati L, Di Lauria N, et al. Disseminated nocardiosis and anti-GMCSF antibodies. European Journal of Clinical Microbiology & Infectious Diseases 2024; 45; 1003-1007.
  3. Arango-Franco CA, Migaud M, Ramírez-Sánchez IC, et al. Anti-GM-CSF neutralizing autoantibodies in Colombian patients with disseminated cryptococcosis. Journal of Clinical Immunology 2023; 43; 921-932.
  4. McCarthy C, Bonella F, OCallahhan M, et al. European Respiratory Society guidelines for the diagnosis and management of pulmonary alveolar proteinosis. European Repiratory Journal 2024; in press.
  5. Horáček J. Alveolární lipoproteinóza. Československá patologie 1985; 21; 186-190.
  6. Čalkovská A. Pľúcny surfaktant v dýchacích cestách. Československá fyziologie 2000; 49(3); 145-151.
  7. Lisá P. Plícní alveolární preoteinóza. Interní medicína 2007; 4; 167-169.
  8. Hutyrová B. Plícní alveolární proteinoza. Vnitrní lékařství 2007; 53(10); 1077-1084.
  9. Dwidedi P, Greis KD. Granulocyte colony/stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrohilic leukemia, and related malignancies. Experimental Hematology 2017; 46; 9-20.
Labels
Anatomical pathology Forensic medical examiner Toxicology
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#